BridgeMD
New treatment option for Coronary Disease
Official title Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease
ClinicalTrials.gov ID: NCT06701968
What this study is testing
- What it's testing
- Diet can play a key role in atherosclerosis and coronary heart disease (CHD), but little interventional data exists, and the mediators of possible anti-atherosclerotic effects of diet are unclear. The investigators will investigate if a healthy Nordic diet (HND) reduces plaque volume, coronary artery calcification (CAC), and plaque inflammation (FAI) in CHD, and examine if changes in gut microbiota may be linked to plaque progression over time.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80
You may be able to join if
- Men and women
- Diagnosis with MI from 2 weeks after diagnosis and with maximum 6 months after diagnosis
- Diagnosis with CCS (e.g. stable angina pectoris)
- Ages 50 to 80 years
- BMI 25-40.
You likely can't join if
- Severe heart failure (NYHA classes III, IV)
- Alcohol intake \>20g/day
- Unwillingness to follow a new prescribed diet for 18 months
- Other diseases implying a short estimated life expectancy (e.g. severe malignant or kidney or liver disease, as judged by consenting physician).
The study team makes the final eligibility decision.
Where it's taking place
- Uppsala, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Uppsala, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.